Keith Jansson

Keith Jansson is a Principal Scientist in Translational Medicine at Genmab, bringing over 11 years of post-graduate experience, including 5 years in the biopharma industry. Previously, they served as an Associate Director at GSK, leading high-throughput functional genomics projects, and as a Postdoctoral Fellow at the National Cancer Institute, where they pioneered novel therapies for advanced prostate cancer. Keith received their Ph.D. in Biological Sciences from the University of Delaware and holds a B.S. in Biology from the University of Massachusetts, Amherst. They are recognized for their strong leadership and collaboration skills in advancing drug discovery and development.